evotec_Nov23_PanOmicsDriven - 6

The PanHunter Platform
" While personalized medicine presents many new and
more effective treatment options for cancer patients,
biomarker testing and targeted therapeutics are still
relatively new in oncology. "
Susanne Munksted, chief precision officer, Diaceutics.
medicine is making better use of its resources, they
point to applications that will soon be within reach,
including applications beyond cancer.
PERSONALIZING CANCER SCREENING
At Exact Sciences, a molecular diagnostics
company that provides a comprehensive suite of
cancer tests, the leadership is optimistic about the
prospects for personalized care, particularly with
respect to the prevention of disease. " Prevention is
our greatest tool in the fight against cancer, " says
Kevin Conroy, Exact's chairman and CEO. " Cardiovascular
mortality has decreased 70% in the last 50
years by focusing on prevention. We can achieve
similar results for cancer. "
Progress, Conroy adds, depends on the development
of appropriate screening technologies. " Cancer
screening should be planned, programmatic, and
personalized, " he insists. " One in two men and one
in three women will develop cancer in their lifetimes,
yet today 70% of incident cancers have no
screening methods. Eradicating cancer will require
a widely available, comprehensive platform of tests
and treatments for patients. "
Conroy highlights five areas and details what
each needs to accomplish:
1. Hereditary cancer assessments should arm people
with the knowledge of their personal risk of
cancer.
2. Screening tests should facilitate earlier detection
of many more types of cancer, including rare
cancers.
3. Therapy guidance tests should help patients and
healthcare providers select the right course of
treatment and avoid overtreatment and undertreatment.
4.
Minimal residual disease tests should assess
whether treatments eliminate cancer, and
monitor for recurrence on a personalized basis.
5. Electronic medical record integration and digital tools
should become simpler and automate the impact
of personalized medicine.
6. " We applaud others who share in our mission, "
Conroy declares. " It will take more people and
organizations getting involved to ensure the
best ideas are combined to yield new, extraordinary
results. "
6
GENengnews.com
https://www.genengnews.com https://www.genengnews.com
evotec_Nov23_PanOmicsDriven

Table of Contents for the Digital Edition of evotec_Nov23_PanOmicsDriven
